Cafepharma Today

October 11 2024 - Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
Teva hands over $450M to resolve kickback lawsuits involving MS drug Copaxone and generics
Roche gets FDA green light for breast cancer drug Itovebi
Sanofi in talks to sell stake in consumer health spinout
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Genentech buys Regor's next-gen CDK inhibitors for $850M
Pharmaphorum
Tuesday, October 1, 2024 - 9:46am
tags:
Regor Therapeutics, Roche, Genentech, CDK inhibitors
CVS Health To Cut 2,900 Jobs But Mum On Potential Break-up
Forbes
Tuesday, October 1, 2024 - 9:45am
tags:
CVS Health, pharmacies, layoffs
As urged by the AHA and others, J&J tells HRSA it is abandoning proposed 340B rebate plan
American Hospital Association
Monday, September 30, 2024 - 9:00pm
tags:
JNJ, 340B, HRSA
Why Viking Therapeutics Stock Topped the Market Today
Motley Fool
Monday, September 30, 2024 - 8:56pm
tags:
Viking Therapeutics, weightloss, VK2735
Small-to-mid-size pharma co’s dominate list of top-paying life-sci workplaces
Medical Marketing and Media
Monday, September 30, 2024 - 8:46pm
tags:
compensation, salaries, life sciences
Amgen, Family Heart Foundation launch at-home cholesterol screening for LDL-C Awareness Day
Medical Marketing and Media
Monday, September 30, 2024 - 8:42pm
tags:
Amgen, Cholesterol Connect, LDL-C, diagnostics, cholesterol
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says
Yahoo/Reuters
Monday, September 30, 2024 - 8:40pm
tags:
Pfizer, consumer health, Haleon
Rivus reveals data to back up muscle-sparing claims of phase 2 obesity drug
Fierce Biotech
Monday, September 30, 2024 - 8:38pm
tags:
Rivus Pharmaceuticals, obesity, heart failure, clinical trials, HU6
Kezar Life Sciences pauses trial for lupus treatment after patient deaths
Reuters
Monday, September 30, 2024 - 8:34pm
tags:
Kezar Life Sciences, lupus, clinical trials, patient deaths
Roche targets more than $3 billion in annual obesity sales
Reuters
Monday, September 30, 2024 - 10:09am
tags:
Roche, Carmot Therapeutics, obesity, diabetes
With post hoc analysis, BridgeBio touts case for acoramidis as FDA decision date draws near
Fierce Biotech
Monday, September 30, 2024 - 9:57am
tags:
BridgeBio, acoramidis, FDA, transthyretin amyloid cardiomyopathy
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
Stat
Monday, September 30, 2024 - 9:56am
tags:
Pfizer, sickle cell disease, Oxbryta, patients
MDMA Drug Developers Reprioritize Following Lykos Rejection in PTSD
BioSpace
Monday, September 30, 2024 - 9:51am
tags:
Lykos Therapeutics, MDMA, PTSD, psychedelics
FDA approves GE HealthCare's diagnostic drug for heart disease
Reuters
Monday, September 30, 2024 - 9:49am
tags:
Medtech, GE Healthcare, diagnostics, Flyrcado, PET, coronary artery disease
Grifols plans to invest $402 million in new industrial centre, El Economista says
Reuters
Monday, September 30, 2024 - 9:47am
tags:
Grifols, Barcelona
AbbVie seeks FDA approval for non-small cell lung cancer treatment
Pharmaceutical Business Review
Monday, September 30, 2024 - 9:45am
tags:
AbbVie, FDA, Teliso-V, non-small cell lung cancer
Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B
Fierce Biotech
Monday, September 30, 2024 - 9:40am
tags:
Eli Lilly, Aktis Oncology, funding, radiopharmaceuticals
After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data
Fierce Pharma
Monday, September 30, 2024 - 9:30am
tags:
Sanofi, JNJ, Sarclisa, Darzalex Faspro, Multiple Myeloma, FDA
Bristol Myers Squibb wins FDA approval for first new schizophrenia drug in 30 years
Medical Marketing and Media
Monday, September 30, 2024 - 9:28am
tags:
Bristol Myers Squibb, FDA, schizophrenia, Cobenfy
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Monday, September 30, 2024 - 9:25am
tags:
Regeneron, Sanofi, Dupixent, COPD, FDA

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

FDA Approves Exact Sciences' Cologuard Plus Non-Invasive Colorectal Cancer Screening Test
pharmexec
FDA Approves Bristol Myers Squibb’s Opdivo in Combination with Chemotherapy for Resectable Non-Small Cell Lung Cancer
pharmexec
Innovative Models for Improving Access and Visibility for Specialty-Lite and Retail Therapies
Drug Channels
Animating for Your Audience: The Right Visual for Your Dev Stage
pharmexec
BCS Financial Introduces Employer Group Gene Therapy Stop Loss
pharmexec
Combating Diseases with Limited Investment Incentives: Q&A with Dr. Claire Wagner
pharmexec
Hologic Launches Breast Cancer Myth Busting Campaign
pharmexec
Pharma Pulse 10/4/24: Regulatory Challenges With Data Collection, Poor Sleep Quality Linked to Dementia & more
pharmexec
Sun Pharma, Philogen Ink Global Commercialization Deal for Fibromun, an Anti-Cancer Immunotherapy
pharmexec

Latest Jobs

Virtual Lead Generation & Sales Specialist - Pharmaceuticals
Jacksonville, Florida, 32290
Syneos Health/ inVentiv Health Commercial LLC
Neuroscience Account Manager (Psychiatry) - Pensacola, FL
Pensacola, Florida, 32573
Vanda Pharmaceuticals
Structural Heart/ICE Territory Sales Manager, Northwest
Issaquah, Washington, 98027
Siemens Medical Solutions USA, Inc
Sales Executive
Everett, Washington, 98213
Abel Consulting
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Territory Account Manager
Orange, California, 92613
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement, CNS - Charlottesville, VA
Roanoke, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago W, IL
Chicago, Illinois,
Otsuka
Pharmaceutical Sales Customer Engagement- Corpus Christi, TX
Corpus Christi, Texas,
Otsuka
Hearing Aid Sales Consultant
Barrington, Rhode Island, 02806
Beltone New England
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information